About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
To inform future pandemic preparedness, it is important that we build upon lessons learned from across the public health supply chain during the COVID-19 pandemic. Timely reauthorization of PAHPA is critical given the centrality of these programs to ensuring pandemic preparedness, supporting a robust biodefense, and supporting resiliency in medical countermeasures. PhRMA and our members are committed to continuing to bolster pandemic preparedness and health care resiliency to make sure our country and American patients are stronger, healthier, and better prepared for the next public health emergency. This is integral to American national security, the health of the American public and future economic stability and growth.
PhRMA Comments on Need for Timely Reauthorization of Pandemic and All Hazards Preparedness Act image
Download Digital IRA Equity Profile (Spanish)
Download Printable IRA Equity Profile (English)
Report
Access to Medicines
PhRMA Comments on Need for Timely Reauthorization of Pandemic and All Hazards Preparedness Act
PhRMA Comments on Need for Timely Reauthorization of Pandemic and All Hazards Preparedness Act image